Mycosis Fungoides
Mycosis Fungoides: Epidemiology in Isfahan, Iran
... Background: Mycosis Fungoides (MF) is the most common and indolent form of Cutaneuse T-cell Lymphomas (CTCL), that usually occurs in old adults. Objectives: To determine epidemiologic features and patients ...
5
Mycosis Fungoides in Relation to Environmental and Occupational Exposures: A Case Control Study in the Tunisian Center
... M., Bousoffara, L., Fetoui, N.G., El Maalel, O., Boughattas, W., Ghariani, N., Denguez- li, M., Brahem, A., El Guedri, S., Kalboussi, H., Chatti, S. and Mrizak, N. (2018) Mycosis Fungoides in Relation to ...
12
Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapy
... Abstract: Mycosis fungoides (MF) is the most common subtype of primary cutaneous T-cell lymphoma. Normally, MF has an indolent course although patients can progress to an advanced disease state (stages ...
5
Clinicopathological Features of Cutaneous Lymphomas and T-Cell Receptor Gamma Gene Rearrangement Studies in Early Stage Mycosis Fungoides
... I/IIA) mycosis fungoides where the histological diagnosis of mycosis fungoides could not be excluded or the diagnosis was suggestive but not ...
207
DNA Content Analysis by Flow Cytometry and Cytogenetic Analysis in Mycosis Fungoides and Sézary Syndrome: DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS
... Flow cytometric (FCM) analysis of DNA content was performed on 82 lymph node and peripheral blood specimens from 46 patients with mycosis fungoides and the Sézary syndrome. Overall, 32 of the 46 patients ...
10
Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides
... Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL). Causative genetic alterations in MF are unknown. The low recurrence of pathogenic small-scale mutations (ie, nucleotide ...
12
Case Report Mycosis fungoides in plaque stage with pronounced eosinophilic infiltration, folliculotropism, and concomitant invasive squamous cell carcinoma
... Abstract: Mycosis fungoides (MF) is a relatively rare cutaneous T-cell malignancy. Only two cases of MF with marked eosinophilia have been reported. In addition, MF with concomitant squamous cell carcinoma ...
8
Analysis of differential β variable region of T cell receptor expression and NAV3/TNFRSF1B gene mutation in mycosis fungoides
... Mycosis fungoides (MF) is a malignant T-cell lymphoma of the skin, which was firstly reported by Alibert in 1806. The incidence rate is accounted to 1 in 300,000 around the world. MF is a chronic disease ...
5
The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus associated disease A study of 50 patients
... For nearly two decades it has been suspected that the cutaneous T cell lymphoma, mycosis fungoides (MF), and its leukemic variant, the Sézary syndrome, are caused by the human T lymphotropic virus ...
9
Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial
... surface of 1.79 m 2 (range: 1.46 – 2.28). Three clinical variants of mycosis fungoides were represented; 6 patients had plaques, 2 had erythroderma, and the rest had atypia of the epidermis. Only five ...
9
<p>Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel</p>
... Abstract: Mycosis fungoides (MF) is a low-grade cutaneous lymphoma accounting for more than half of primary cutaneous T-cell lymphomas (CTCLs). Due to the rarity of CTCL, random- ized studies are lacking, ...
11
Emerging treatment options for early mycosis fungoides
... Abstract: Mycosis fungoides is a candidate for skin-directed therapies in its initial ...localized mycosis fungoides that do not respond to routine treatments; nevertheless, more studies on ...
9
Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides
... Mycosis fungoides (MF) is a rare disease that represents the most common type of primary CTCL, which is characterized by a clonal proliferation of malignant lymphocytes in the ...
5
THE VALUE OF TOX AS A DIAGNOSTIC MARKER FOR MYCOSIS FUNGOIDES (MF)
... Background/Aim: Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL). Differentiation of MF from its benign mimickers is important to ensure proper management. TOX is a ...
8
The utility of bexarotene in mycosis fungoides and Sézary syndrome
... Abstract: Cutaneous T-cell lymphoma (CTCL) is an umbrella term that encompasses a group of neoplasms that have atypical T-lymphocytes in the skin. Mycosis fungoides (MF) is the most common type of CTCL and ...
7
Folliculotropic Mycosis Fungoides as a Posttransplant Lymphoproliferative Disorder
... Posttransplant lymphoproliferative disorder (PTLD) is a known complication of solid organ transplantation. The majority are B cell in origin and related to Epstein-Barr virus infection. T-cell PTLD is much less common; ...
7
Mycosis Fungoides in Iraqi Patients—Clinical, Histopathological and Immunohistochemical Study
... Mycosis fungoides (MF) is the most common form of cutaneous T cell lymphoma (CTCL) and accounts for al- most 50% of all primary cutaneous lymphomas ...
9
Clinicopathological Evaluation and Outcome of Mycosis Fungoides
... Although mycosis fungoides is the most common cutaneous T-cell lymphoma, its etiopathogenesis has not been clarified definitively and there is no standard and curative treatment ...with mycosis ...
5
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
... dermatitis reported is similar to other studies, this study also used adjuvant treatment in 98.3% of patients, including topical steroids, psoralen + ultraviolet A, local rad[r] ...
14
Thaller, Eva (2006): Untersuchung zur Korrelation von Immunphänotyp und Klonalität bei Mycosis fungoides mittels Lasermikrodissektion. Dissertation, LMU München: Medizinische Fakultät
... Angenommen die CD4/CD3-positiven Zellen zeigen ein monoklonales Rearrangement: Werden nun mit Hilfe der LCM in erster Linie CD3-positive Zellen untersucht, so befinden sich unter i[r] ...
82